Clinical characteristics and risk score for poor clinical outcome of acute ischemic stroke patients treated with intravenous thrombolysis therapy

被引:11
作者
Yue, Yun-hua [1 ]
Li, Zhi-zhang [1 ]
Hu, Liang [1 ]
Zhu, Xiao-qiong [1 ]
Xu, Xu-shen [1 ]
Sun, Hong-xian [1 ]
Wan, Zhi-wen [1 ]
Xue, Jie [1 ]
Yu, De-hua [2 ]
机构
[1] Tongji Univ, Dept Neurol, Yangpu Hosp, Sch Med, Shanghai, Peoples R China
[2] Tongji Univ, Dept Gen Med, Yangpu Hosp, Sch Med, Shanghai, Peoples R China
关键词
outcome; stroke; tissue plasminogen activator; C-REACTIVE PROTEIN; BLOOD-PRESSURE; HYPERGLYCEMIA; HEMORRHAGE; PREDICTION; MORTALITY; DAMAGE; SCALE;
D O I
10.1002/brb3.1251
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Background Tissue plasminogen activator (t-PA) is an effective therapy for acute ischemic stroke, but some patients still have poor clinical outcome. In this study, we investigated clinical characteristics of stroke patients and determined predictors for poor clinical outcome in response to t-PA treatment. Methods Clinical data from 247 patients were retrospectively reviewed. Clinical parameters that were associated with survival of patients were analyzed. Areas under receiver operating characteristic curves (ROC) were used to determine the feasibility of using various combinations of the clinical parameters to predict poor clinical response. The clinical outcome was defined according to the changes in Modified Rankin Scale. Results Overall, 145 patients had improved/complete recovery, 73 had no change, and 29 had worsening conditions or died during the in-clinic period. A univariate analysis showed that baseline characteristics including age, CRP, blood glucose level, systolic blood pressure, and admission NIHSS were significantly different (p 0.05) among patients with different clinical outcome. A further multivariate analysis was then performed. Variables associated with poor clinical outcome (worsening/death) (p < 0.1) were included in the logistic regression model. Four parameters were retained in the model: Age, CRP, Blood glucose level, and Systolic blood pressure (ACBS). To allow a convenient usage of the ACBS classifier, the parameters were put into a scoring system, and the score at 7.7 was chosen as a cut-off. The ROC curve of this ACBS classifier has an area under the curve (AUC) of 0.7788, higher than other individual parameters. The ACBS classifier provided enhanced sensitivity of 69.2% and specificity of 74.3%. Conclusion The ACBS classifier provided a satisfactory power in estimating the patients' clinical outcome. After further validating, the classifier may provide important information to clinicians for making clinical decisions.
引用
收藏
页数:8
相关论文
共 30 条
[11]   Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J].
Katzan, IL ;
Furlan, AJ ;
Lloyd, LE ;
Frank, JI ;
Harper, DL ;
Hinchey, JA ;
Hammel, JP ;
Qu, A ;
Sila, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1151-1158
[12]  
Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9
[13]   PREDICTING OUTCOME OF IV THROMBOLYSIS-TREATED ISCHEMIC STROKE PATIENTS: THE DRAGON SCORE [J].
Kent, Thomas A. ;
Mandava, Pitchiah .
NEUROLOGY, 2012, 78 (17) :1368-1368
[14]   Blood pressure and clinical outcomes in the international stroke trial [J].
Leonardi-Bee, J ;
Bath, PMW ;
Phillips, SJ ;
Sandercock, PAG .
STROKE, 2002, 33 (05) :1315-1320
[15]   Hyperglycemia in acute stroke [J].
Lindsberg, PJ ;
Roine, RO .
STROKE, 2004, 35 (02) :363-364
[16]   The HAT Score A simple grading scale for predicting hemorrhage after thrombolysis [J].
Lou, M. ;
Safdar, A. ;
Mehdiratta, M. ;
Kumar, S. ;
Schlaug, G. ;
Caplan, L. ;
Searls, D. ;
Selim, M. .
NEUROLOGY, 2008, 71 (18) :1417-1423
[17]   Haemorrhage risk after thrombolysis-the SEDAN score [J].
Lyden, Patrick D. .
NATURE REVIEWS NEUROLOGY, 2012, 8 (05) :246-247
[18]  
Mazaheri S, 2018, ARCH IRAN MED, V21, P8
[19]   Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator [J].
Menon, Bijoy K. ;
Saver, Jeffrey L. ;
Prabhakaran, Shyam ;
Reeves, Mathew ;
Liang, Li ;
Olson, DaiWai M. ;
Peterson, Eric D. ;
Hernandez, Adrian F. ;
Fonarow, Gregg C. ;
Schwamm, Lee H. ;
Smith, Eric E. .
STROKE, 2012, 43 (09) :2293-+
[20]   C-reactive protein and outcome after ischemic stroke [J].
Muir, KW ;
Weir, CJ ;
Alwan, W ;
Squire, IB ;
Lees, KR .
STROKE, 1999, 30 (05) :981-985